The listed company Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, entered into a senior secured loan agreement with funds managed by the US company Athyrium Capital Management. The CHF 75 million senior secured loan will be used
Tags :Thomas Goossens
One Swiss Bank and its shareholders entered into a merger agreement with Banque Profil de Gestion, which closed on June 1, 2021 following the grant of the necessary authorizations and the fulfilment of other conditions precedent pursuant
